Literature DB >> 23553728

Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation.

Rabia Chaudhry1, Aditi Kidambi, Megan Hwa Brewer, Anthony Antonellis, Katherine Mathews, Garth Nicholson, Marina Kennerson.   

Abstract

INTRODUCTION: Charcot-Marie-Tooth (CMT) disease is a group of peripheral neuropathies affecting both motor and sensory nerves. CMTX3 is an X-linked CMT locus, which maps to chromosome Xq26.3-q27.3. Initially, CMTX3 was mapped to a 31.2-Mb region in 2 American families. We have reexamined 1 of the original families (US-PED2) by next generation sequencing.
METHODS: Three members of the family underwent exome sequencing. Candidate variants were validated by PCR and Sanger sequencing analysis.
CONCLUSION: No pathogenic coding variants localizing to the CMTX3 region were identified. However, exome sequencing identified a known BSCL2 mutation (N88S). This study demonstrates the power of exome sequencing as a tool to identify gene mutations for a small family in the absence of statistically significant linkage data.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553728      PMCID: PMC5175269          DOI: 10.1002/mus.23743

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  23 in total

1.  Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation.

Authors:  Michaela Auer-Grumbach; Beate Schlotter-Weigel; Hanns Lochmüller; Gertrud Strobl-Wildemann; Piet Auer-Grumbach; Renate Fischer; Hans Offenbacher; Ernst Bernhard Zwick; Tanja Robl; Gerald Hartl; Hans-Peter Hartung; Klaus Wagner; Christian Windpassinger
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

2.  N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress.

Authors:  Takuya Yagi; Daisuke Ito; Yoshihiro Nihei; Tadayuki Ishihara; Norihiro Suzuki
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

3.  Genetic and clinical aspects of Charcot-Marie-Tooth's disease.

Authors:  H Skre
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

4.  Linkage analyses between dominant X-linked Charcot-Marie-Tooth disease, and 15 Xq11-Xq21 microsatellites in a new large family: three new markers are closely linked to the gene.

Authors:  E Le Guern; N Ravise; M Gugenheim; A Vignal; C Penet; P Bouche; J Weissenbach; Y Agid; A Brice
Journal:  Neuromuscul Disord       Date:  1994 Sep-Nov       Impact factor: 4.296

5.  X-linked dominant Charcot-Marie-Tooth disease: suggestion of linkage with a cloned DNA sequence from the proximal Xq.

Authors:  A Gal; J Mücke; H Theile; P F Wieacker; H H Ropers; T F Wienker
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Proof of genetic heterogeneity in X-linked Charcot-Marie-Tooth disease.

Authors:  I G Huttner; M L Kennerson; S W Reddel; D Radovanovic; G A Nicholson
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

Review 7.  Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics.

Authors:  V V Ionasescu
Journal:  Muscle Nerve       Date:  1995-03       Impact factor: 3.217

8.  Evidence of a founder haplotype refines the X-linked Charcot-Marie-Tooth (CMTX3) locus to a 2.5 Mb region.

Authors:  Megan Brewer; Febriani Changi; Anthony Antonellis; Kurt Fischbeck; Patsie Polly; Garth Nicholson; Marina Kennerson
Journal:  Neurogenetics       Date:  2008-05-06       Impact factor: 2.660

9.  The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V.

Authors:  Joy Irobi; Peter Van den Bergh; Luciano Merlini; Christine Verellen; Lionel Van Maldergem; Ines Dierick; Nathalie Verpoorten; Albena Jordanova; Christian Windpassinger; Els De Vriendt; Veerle Van Gerwen; Michaela Auer-Grumbach; Klaus Wagner; Vincent Timmerman; Peter De Jonghe
Journal:  Brain       Date:  2004-07-08       Impact factor: 13.501

10.  Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome.

Authors:  Christian Windpassinger; Michaela Auer-Grumbach; Joy Irobi; Heema Patel; Erwin Petek; Gerd Hörl; Roland Malli; Johanna A Reed; Ines Dierick; Nathalie Verpoorten; Thomas T Warner; Christos Proukakis; Peter Van den Bergh; Christine Verellen; Lionel Van Maldergem; Luciano Merlini; Peter De Jonghe; Vincent Timmerman; Andrew H Crosby; Klaus Wagner
Journal:  Nat Genet       Date:  2004-02-22       Impact factor: 38.330

View more
  5 in total

1.  ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia.

Authors:  Thomas Musacchio; Ann-Kathrin Zaum; Nurcan Üçeyler; Claudia Sommer; Nora Pfeifroth; Karlheinz Reiners; Erdmute Kunstmann; Jens Volkmann; Simone Rost; Stephan Klebe
Journal:  J Neurol       Date:  2016-10-13       Impact factor: 4.849

2.  Whole Genome Sequencing Identifies a 78 kb Insertion from Chromosome 8 as the Cause of Charcot-Marie-Tooth Neuropathy CMTX3.

Authors:  Megan H Brewer; Rabia Chaudhry; Jessica Qi; Aditi Kidambi; Alexander P Drew; Manoj P Menezes; Monique M Ryan; Michelle A Farrar; David Mowat; Gopinath M Subramanian; Helen K Young; Stephan Zuchner; Stephen W Reddel; Garth A Nicholson; Marina L Kennerson
Journal:  PLoS Genet       Date:  2016-07-20       Impact factor: 5.917

Review 3.  Hereditary Spastic Paraplegia: An Update.

Authors:  Arun Meyyazhagan; Antonio Orlacchio
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 5.923

Review 4.  Clinical implications of genetic advances in Charcot-Marie-Tooth disease.

Authors:  Alexander M Rossor; James M Polke; Henry Houlden; Mary M Reilly
Journal:  Nat Rev Neurol       Date:  2013-09-10       Impact factor: 42.937

5.  Exome Sequencing and Gene Prioritization Correct Misdiagnosis in a Chinese Kindred with Familial Amyloid Polyneuropathy.

Authors:  Hui Chen; Xueya Zhou; Jing Wang; Xi Wang; Liyang Liu; Shinan Wu; Tengyan Li; Si Chen; Jingwen Yang; Pak Chung Sham; Guangming Zhu; Xuegong Zhang; Binbin Wang
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.